CN Patent

CN109641874A — 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体

Assigned to C4 Pharmaceutical Co · Expires 2019-04-16 · 7y expired

What this patent protects

本发明提供了具有碳连接的E3泛素连接酶靶向部分(降解决定子)的降解决定子体，所述E3泛素连接酶靶向部分可连接至针对经选择进行体内降解的蛋白质的靶向配体，本发明还提供了其使用方法和组合物以及它们的制备方法。

USPTO Abstract

本发明提供了具有碳连接的E3泛素连接酶靶向部分(降解决定子)的降解决定子体，所述E3泛素连接酶靶向部分可连接至针对经选择进行体内降解的蛋白质的靶向配体，本发明还提供了其使用方法和组合物以及它们的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109641874A
Jurisdiction
CN
Classification
—
Expires
2019-04-16
Drug substance claim
No
Drug product claim
No
Assignee
C4 Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.